Latest Product News
INTEGRA’s Automated Pipetting Solutions Improve Accuracy and Reproducibility for MicroRNA-Based Diagnostics
MiRXES, a biotechnology company based in Singapore, is relying on a range of INTEGRA pipetting systems to increase the speed and precision of its RT-qPCR workflows.
SonALAsense Forges Ahead With First Patient Dosing for Devastating Childhood Brain Cancer
Multisite study will test sonodynamic therapy in pediatric patients with diffuse intrinsic pontine glioma (DIPG).
Fast and Simple Picking of Whole Tissue Samples From Storage
Ziath announce the launch of the Mohawk 48 tube selector and picker. Designed to select and pick wide, heavy, or tall tubes - this new system is perfect for retrieving individual whole tissue samples from storage.
Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration
Avacta Group plc announces that the US Food and Drug Administration has granted Orphan Drug Designation to the company’s lead pre|CISION drug candidate, AVA6000, for treatment of soft tissue sarcoma.
Thermo Fisher Scientific Launches CE-IVD (IVDD) Next-Generation Sequencing Test and Analysis Software To Expand Access to Precision Oncology Biomarker Testing
To meet the need for rapid genomic insights, Thermo Fisher Scientific has launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx for use in clinical labs.
Indica Labs Announces Collaboration With The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics
Indica Labs and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) have announced an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.
ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
ERS Genomics Limited is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD.
OncoBone Ventures Receives HMRC Adcance Assurance for SEIS/EIS
OncoBone Ventures is pleased to announce that it has received Advance Assurance from HMRC that investments in the Company can qualify for tax relief under the Seed Enterprise Investment Scheme (SEIS)/Enterprise Investment Scheme (EIS).
Voltron Therapeutics, Inc. Announces Definitive Proof of Concept Data for its Lead Oncology Candidate
Voltron Therapeutics, Inc. has announced that data from the previously announced Study ‘098 demonstrated clear Proof-of Concept for VTX-067 in the treatment of HPV-related cancers.
CN Bio Opens New Laboratory Facilities To Extend Organ-on-a-Chip Contract Research Services Capabilities
CN Bio today announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services.